Lisa C. Gill

JPMorgan's Lisa C. Gill downgraded the rating on Diplomat Pharmacy Inc (NYSE: DPLO) from Overweight to Neutral, while lowering the price target from $52 to $30. On February 29, the company reported robust 4Q15 results, with the adjusted EPS ahead of the consensus and the estimate. However, Gill...

Shares of Express Scripts Holding Company (NASDAQ: ESRX) have been volatile in 2015 and are up 1.33 percent year-to-date. JP Morgan’s Lisa C. Gill maintained an Overweight rating on the company, with a price target of $105. The company appears to be competitively positioned to take...

Shares of Express Scripts Holding Company (NASDAQ: ESRX) have been volatile in 2015 and are trading around their January level of $85. JP Morgan’s Lisa C. Gill maintained an Overweight rating on the company. Express Scripts’ patient assistance programs mischaracterized, they...

In a report published Thursday, J.P. Morgan analyst Lisa C. Gill upgraded Quality Systems (NASDAQ: QSII) from Underweight to Neutral, and raised the price target from $17.00 to $20.00. In the report, J.P. Morgan noted, “Last evening, Quality Systems announced that it had reached an agreement...

In a report published Thursday, J.P. Morgan analyst Lisa C. Gill reiterated an Overweight rating and $45.00 price target on Omnicare (NYSE: OCR). In the report, J.P. Morgan noted, “As part of OCR Week, today we focus on reimbursement in OCR's LTC pharmacy business. While there continues to be...

In a report published Thursday, J.P. Morgan analyst Lisa C. Gill reiterated an Overweight rating on McKesson (NYSE: MCK). In the report, J.P. Morgan noted, “We attended McKesson's annual Investor Day in Boston today where management confirmed FY 2014 guidance of $7.90-$8.20. Additionally...